SenesTech Announces Warrant Exercise for $1.1 Million in Gross Proceeds

Core Viewpoint - SenesTech, Inc. has entered into definitive agreements for the immediate exercise of certain outstanding warrants, allowing the purchase of 374,718 shares at a reduced exercise price, aiming to raise capital for working and corporate purposes [1][3]. Group 1: Warrant Exercise and Financial Details - The existing warrants, originally priced at $4.35 per share, will now be exercised at $2.90 per share, generating approximately $1.1 million in gross proceeds before fees [1][3]. - New short-term warrants will be issued, potentially raising an additional $4.3 million if fully exercised [3][5]. - The new short-term warrants will allow the purchase of up to 1,498,872 shares at the same reduced price of $2.90 per share [5]. Group 2: Regulatory and Compliance Information - The resale of shares from the existing warrants has been registered under an effective registration statement [4]. - The new short-term warrants have not been registered under the Securities Act of 1933, meaning they cannot be sold in the U.S. without proper registration or exemption [6]. Group 3: Company Overview - SenesTech focuses on humane pest management solutions, particularly through its Evolve™ rodent birth control product, aiming to create healthier environments and reduce reliance on traditional poisons [8].